20/20 Biolabs, Inc. (AIDX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$2.0M

Net Income/Loss (FY2025)

-$3.7M

Total Assets (FY2025)

$4.1M

Total Equity (FY2025)

-$19.2K

Cash Flows from Operating Activities (FY2025)

-$1.9M

Source: 20/20 Biolabs, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.